Maca Root: An Evidence Review of Hormonal Effects, Fertility, and Adaptogenic Properties
9 May 2026 · 12 min read
This article is for educational purposes only. Maca root is a food and supplement, not a medicine. Nothing here constitutes medical advice. Consult a qualified healthcare practitioner before using maca if you are pregnant, breastfeeding, have a thyroid condition, or take prescription medications.
Introduction
Maca (Lepidium meyenii) is a cruciferous root vegetable cultivated in the Peruvian Andes at altitudes between 4,000 and 4,500 metres — some of the harshest agricultural terrain on Earth. For at least 2,000 years, indigenous communities in the Junín plateau have grown maca as both a staple food and a traditional medicine, using it to support energy, stamina, reproductive function, and resilience under physiological stress.
Modern research interest has accelerated since the early 2000s. The central question driving that interest is whether maca's traditional reputation for hormonal and fertility effects is supported by clinical evidence — and, if so, by what biological mechanism. The answer that has emerged from a now-substantial body of randomised controlled trials is nuanced: maca appears to produce real, measurable effects on menopausal symptoms, libido, sperm parameters, and mood — but not through the mechanism most people assume. Understanding that distinction is the key to evaluating the evidence honestly.
Plant Biochemistry: What Makes Maca Active?
Maca's bioactive profile is unlike any other cruciferous plant. Three compound classes are considered primarily responsible for its biological effects.
Macamides and macaenes are the most pharmacologically distinctive. Macamides are N-benzyl fatty acid amides unique to Lepidium meyenii — they are not found in any other food plant. Macaenes are the corresponding polyunsaturated fatty acid precursors. Together, these compounds are believed to be the primary drivers of maca's effects on sexual function and mood, and they are now used as the standardisation marker in quality extracts.
Glucosinolates, particularly glucotropaeolin, are shared with other brassica vegetables but are present at higher concentrations in maca. Glucosinolates have demonstrated anti-tumour and anti-inflammatory activity in preclinical models. They are also the source of a relevant safety consideration discussed below.
Alkaloids of the lepidine family — including lepidine B, C, D, and E — contribute to what researchers describe as maca's adaptogenic activity, likely through modulation of the hypothalamic-pituitary-adrenal (HPA) axis. These alkaloids have been shown to inhibit monoamine oxidase and interact with dopaminergic signalling pathways in animal models.
Colour Variants
Commercial maca comes in three main phenotypes: yellow, red, and black. Yellow maca is by far the most common and is the variety used in the majority of human clinical trials, making it the default reference point for evidence-based claims. Black maca has attracted specific research interest for male fertility (discussed below). Red maca has shown some promise in preclinical prostate models but has very limited human trial data.
Gelatinization
Raw maca powder has a high starch content that can cause digestive discomfort and reduces bioavailability of key bioactives. Gelatinization — a heat treatment process that removes most of the starch — substantially improves tolerability and is used in all reputable clinical trial preparations. Importantly, the heat process does not degrade macamides, macaenes, or glucosinolates at the levels required for commercial processing. When comparing products, gelatinized maca is the formulation with the strongest research backing.
Mechanism: How Does Maca Affect Hormones?
This is where the evidence diverges sharply from popular marketing claims — and where the science becomes genuinely interesting.
The most consistent finding across human RCTs is that maca does not significantly alter circulating oestrogen, testosterone, FSH, LH, SHBG, or prolactin. Multiple placebo-controlled trials have measured these hormones at baseline and after weeks to months of supplementation and found no statistically significant differences. This has been replicated in both pre- and postmenopausal women, in healthy men, and in men presenting with subfertility.
This finding rules out the most obvious proposed mechanism: direct phytoestrogenic or phytoandrogenic activity. Unlike soy isoflavones or red clover, maca is not oestrogenic. It does not bind oestrogen receptors. It does not raise or lower oestrogen levels measurably. This is a critical clinical distinction — it means maca may be appropriate for women who wish to avoid phytoestrogen exposure (including those with oestrogen-sensitive conditions, pending medical advice) in a way that soy-based supplements are not.
So what is actually happening? Current mechanistic hypotheses, supported by animal studies and some human data, point to three non-hormonal pathways:
-
HPA axis modulation. Maca's alkaloids appear to influence the body's central stress-response circuitry at the hypothalamic-pituitary level. This could explain improvements in mood, anxiety, and energy without requiring changes in sex hormone concentrations.
-
Endocannabinoid system interaction. Macamides share structural similarity with N-acylethanolamines — endogenous ligands for cannabinoid receptors. In vitro studies show macamide inhibition of fatty acid amide hydrolase (FAAH), the enzyme that breaks down anandamide. This may partially explain effects on mood and sexual function.
-
Central neurotransmitter modulation. Lepidine alkaloids demonstrate monoamine oxidase inhibitory activity in preclinical models, which could contribute to maca's observed effects on libido and depression scores through dopaminergic and serotonergic pathways.
This mechanistic picture — centrally acting, not peripherally hormonal — is consistent with the clinical data and is an active area of investigation. For a broader view of how adaptogens modulate stress-response systems through non-hormonal pathways, the herbal adaptogen research compendium covers comparative mechanistic evidence across the major botanical adaptogens.
Evidence in Menopausal Women
The strongest and most replicated human evidence for maca sits in the menopausal symptom literature.
Meissner et al. (2006) conducted a placebo-controlled crossover study in 124 postmenopausal women using 2 grams per day of pre-gelatinized maca. Participants receiving maca showed statistically significant reductions in hot flushes, night sweats, depression, and anxiety compared to placebo. Crucially, serum oestrogen levels did not change — confirming the non-oestrogenic mechanism. The researchers proposed that maca acts on the hypothalamic-pituitary axis to normalise downstream symptom patterns without directly altering ovarian hormone output.
Stojanovska et al. (2015) enrolled postmenopausal women in a double-blind RCT using 3.5 grams per day of maca. Results showed significant improvements in sexual dysfunction scores, reduced diastolic blood pressure, and improved psychological wellbeing compared to placebo. Again, no significant changes in oestrogen or FSH were observed.
Gonzales et al. (2016) published a systematic review of available maca trials in menopausal and postmenopausal populations and found consistent evidence across studies for symptom improvement — particularly vasomotor symptoms (hot flushes, night sweats) and psychological symptoms (anxiety, depression). The review noted that sample sizes remained modest and called for larger trials, but affirmed that the directional evidence was coherent and replicated.
The takeaway from this body of literature is that maca appears to be a genuinely useful intervention for menopausal symptom management — not because it raises oestrogen, but likely because it modulates the central processes that drive vasomotor and psychological symptoms when oestrogen declines.
Evidence in Sexual Function
Maca's traditional reputation as an aphrodisiac has attracted specific clinical investigation. The evidence is modest but directionally consistent.
Dording et al. (2008) conducted a double-blind RCT in patients experiencing antidepressant-induced sexual dysfunction (both men and women on SSRIs). Participants receiving 3 grams per day of maca reported significantly greater improvement in sexual function compared to placebo, as measured on standardised rating scales. This is a particularly informative study because SSRI-induced sexual dysfunction is a well-characterised, pharmacologically explained phenomenon — and maca's benefits occurring in this population support a centrally-mediated mechanism, likely involving dopaminergic pathways.
Gonzales (2002) reported that postmenopausal women using 3 grams per day of maca experienced improvements in sexual desire at 12 weeks. This improvement was not correlated with changes in oestrogen or testosterone levels, again pointing away from direct hormonal mediation.
Evidence in Male Fertility and Libido
Maca has attracted sustained research interest in male reproductive function, and this is arguably the area with the most rigorous human trial data available.
Gonzales et al. (2001) conducted a landmark 9-week randomised, double-blind, placebo-controlled trial in healthy men aged 24–44. Men receiving 1.5 grams or 3 grams per day of maca showed significant improvements in sperm count and sperm motility compared to placebo at 8 and 12 weeks. Testosterone, LH, FSH, and prolactin levels did not change significantly in any group. This study established the foundational finding that maca improves male reproductive parameters through a hormone-independent mechanism.
Gonzales et al. (2002) followed up with a 4-month RCT confirming these semen quality findings. Sperm concentration and motility improved in the maca groups compared to placebo, and again no significant changes in serum hormone levels were detected. This study also measured self-reported libido using a validated questionnaire and found that maca improved libido scores at 8 weeks — independently of testosterone levels. The decoupling of libido improvement from testosterone change is a key finding that supports the central/neurotransmitter mechanism over direct androgen effects.
Gonzales-Castañeda (2008) compared yellow and black maca varieties in male subjects and found that black maca produced a stronger effect on sperm count than yellow maca. This is one of the clearest pieces of human evidence for differentiated activity between colour variants, and it makes black maca the more specific choice for male fertility support, although yellow maca also showed benefit.
Practical Implication
For men seeking to support sperm parameters, the available evidence supports a dose of 1.5–3 grams per day of gelatinized maca over a minimum of 8–12 weeks. Black maca may offer a marginal advantage for this specific application. No expectation of testosterone change should be formed based on the current trial literature.
Evidence in Athletic Performance
This is the area where the evidence base is thinnest and claims should be made most cautiously.
Stojanovska et al. (2015) included a small exercise sub-study involving 14 male cyclists who supplemented with maca for 2 weeks and then completed a 40km time trial. Their times improved compared to their own baseline. However, this sub-study lacked an adequate parallel placebo control arm for this specific outcome, which severely limits interpretability. The improvement may reflect genuine ergogenic effect, practice effect, or placebo response.
No large, well-controlled human RCT has established maca as an evidence-based ergogenic aid. The preclinical animal data on endurance is more consistently positive, but translating rodent endurance protocols to human athletic performance claims is not well-supported. Current data: insufficient to make confident athletic performance claims.
Safety and Tolerability
Maca's tolerability profile across all major human trials is excellent. No serious adverse events were attributed to maca in any published RCT. Minor gastrointestinal complaints (bloating, flatulence) have occasionally been reported with raw maca powder and are substantially reduced with gelatinized preparations.
Two specific considerations deserve attention:
Thyroid and goitrogens. Maca contains glucosinolates, which at high intake can interfere with thyroid iodine uptake — a concern shared with other brassica vegetables eaten in large quantities. Gelatinization reduces glucosinolate content substantially. For most people at recommended doses, this is not a clinically meaningful risk. However, individuals with existing thyroid dysfunction — particularly hypothyroidism — should exercise caution and consult an endocrinologist or GP before supplementing, particularly with raw maca powder.
Pregnancy. There are no adequately powered human safety trials in pregnant women. Maca has been consumed as a food in Peru for millennia, but supplemental doses are higher than typical dietary intake. In the absence of safety data, maca supplementation should be avoided during pregnancy and breastfeeding.
Dosing and Forms: What the Evidence Supports
The clinically studied dose range is 1.5–3.5 grams per day of gelatinized maca. The most commonly used dose in positive RCTs is 3 grams per day, taken as a single dose or divided across meals.
Gelatinized vs raw: Gelatinized maca is the evidence-based choice. It has superior digestibility, equivalent or better bioavailability of key bioactives, and substantially lower goitrogen content.
Powder vs capsules: Pharmacologically equivalent at the same dose. Capsules offer convenience and taste neutrality; powder can be added to smoothies or food.
Colour variant selection:
- Yellow maca: most studied, most available, appropriate for general use including menopausal symptoms and libido in both sexes
- Black maca: supported for male sperm count and motility specifically
- Red maca: insufficient human trial data for specific recommendations
Duration: Effects on sperm parameters and menopausal symptoms have been observed from 8–12 weeks of consistent use. Short-term use under 4 weeks is unlikely to produce the outcomes observed in the literature.
Comparison with Other Adaptogens
Maca's non-oestrogenic, centrally-mediated mechanism distinguishes it clearly from phytoestrogenic herbs such as red clover and soy isoflavones. For women who want support for menopausal symptoms without oestrogen receptor activity, maca presents a different risk-benefit profile to oestrogenic botanicals.
Within the adaptogen category, maca's closest mechanistic comparisons are herbs that act on HPA axis regulation rather than direct hormone production. Korean red ginseng adaptogenic effects have been similarly studied for libido and performance, with a different bioactive profile (ginsenosides acting on nitric oxide pathways) producing some overlapping outcomes. Likewise, research on Siberian ginseng and adaptogenic herbs covers HPA modulation through eleutherosides — a mechanistically distinct but functionally parallel approach. For a broader adaptogen comparison, schisandra's lignan-based activity provides another contrasting mechanistic model. Maca's macamide-endocannabinoid pathway makes it genuinely novel within this class.
Summary
The clinical evidence for maca root, while not without gaps, is more substantial and more rigorously characterised than for most botanical supplements. Key evidence-based conclusions:
- Maca reliably improves menopausal symptoms — including hot flushes, night sweats, anxiety, and depression — without altering oestrogen levels
- Maca improves self-reported libido in both men and women, likely through central neurotransmitter modulation rather than androgenic or oestrogenic mechanisms
- Maca (particularly black maca) improves sperm count and motility in men, again without changing testosterone, LH, FSH, or prolactin
- Maca is not a phytoestrogen — this distinguishes it clinically from soy isoflavones and red clover
- Athletic performance evidence is preliminary and insufficient to support strong claims
- Safety is excellent at studied doses in gelatinized form; thyroid caution applies; avoid in pregnancy
The clinically supported dose is 1.5–3.5 grams per day of gelatinized maca, with a minimum 8-week trial period to assess individual response. Yellow maca covers most evidence-based applications; black maca is the more specific choice for male sperm parameters.
This review draws on published human randomised controlled trials. Study citations are referenced by author and year. The evidence landscape continues to evolve and this article reflects the published literature as of mid-2026.